Advertisement
U.S. markets open in 6 hours 40 minutes

Aethlon Medical, Inc. (AEMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
0.4032-0.0011 (-0.27%)
At close: 04:00PM EST
0.4145 +0.01 (+2.80%)
After hours: 07:15PM EST

Aethlon Medical, Inc.

11555 Sorrento Valley Road
Suite 203
San Diego, CA 92121
United States
619 941 0360
https://www.aethlonmedical.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 14

Key Executives

NameTitlePayExercisedYear Born
Mr. James B. Frakes M.B.A.CEO, CFO, Secretary & Director416.45kN/A1957
Mr. Guy F. Cipriani BS (Eng.), MBASenior VP & COO378.06kN/A1971
Dr. Steven P. LaRosa M.D.Chief Medical Officer430kN/A1968
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Corporate Governance

Aethlon Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.